arrow
E

Emily J. Cicali

university of florida
H指数:14
被引数:677

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Defining Core Functions and Forms for the Implementation of Pharmacogenomics Testing in Primary Care

定义核心功能与形式以在初级保健中实施药物基因组学检测

2026-10-310
OA
CYP2D6-Guided Opioid Therapy for Chronic Pain: A Multi-Center Pragmatic Randomized Controlled Trial

CYP2D6指导下的阿片类药物疗法用于慢性疼痛:一项多中心实用性随机对照试验

2026-10-220
OA
A Pilot Randomized Study of NAT2 and YEATS4 Pharmacogenetic Return of Results in Adults with Hypertension and African Ancestry: The GUARDD ‐ US PGx Study

一项关于NAT2和YEATS4药物基因组学结果反馈在具有非洲血统的高血压成人中的随机试点研究:GUARDD‐US PGx研究

2026-10-180
OAAI
Trial of Preemptive Pharmacogenetic Testing in Underserved Patients (TOPP UP): Study Framework and Baseline Characteristics of Randomized Controlled Trial Participants

在弱势患者中进行的预防性药物基因组学检测试验(TOPP UP):随机对照试验的研究框架和参与者基线特征

2026-02-230
OAAI
Implementing a pragmatic clinical trial to tailor opioids for chronic pain on behalf of the IGNITE ADOPT PGx investigators
2024-08-231
OA
Rationale and design for a pragmatic randomized trial to assess gene-based prescribing for SSRIs in the treatment of depression

一项实用的随机试验的原理和设计,以评估基于基因的ssri处方治疗抑郁症

2024-06-111
OAAI
Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators

代表IGNITE采用PGx研究人员进行务实的临床试验,以定制用于急性疼痛的阿片类药物

2022-08-0412
OAAI
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing
2021-12-0137
OAAI